Samvardhana Motherson International Grants 23,211,370 Employee Stock Options Under ESOP Scheme 2025
Samvardhana Motherson International's Nomination and Remuneration Committee approved the grant of 23,211,370 Employee Stock Options on May 04, 2026, under ESOP Scheme 2025, at an exercise price of INR 121.21 per option. Each option corresponds to one fully paid-up equity share of face value Re. 1/-. The scheme, compliant with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, stipulates a vesting period of one to five years from the grant date and an exercise window of up to three years from each vesting date. The scheme is administered by the Motherson ESOP Trust and covers employees of the Company as well as its group and subsidiary companies in India and abroad.

*this image is generated using AI for illustrative purposes only.
Samvardhana Motherson International Limited's Nomination and Remuneration Committee (NRC) convened on May 04, 2026, and approved the grant of Employee Stock Options (ESOPs) to eligible employees under the "Samvardhana Motherson International Limited – Employee Stock Option Scheme 2025" (ESOP Scheme 2025). The committee meeting commenced at 1540 Hours (IST) and concluded at 1610 Hours (IST). This grant follows earlier disclosures dated June 19, 2025 and August 23, 2025, in which the Board of Directors and Shareholders of the Company had respectively approved the formulation, adoption, and implementation of the ESOP Scheme 2025. The disclosure has been made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Details of the ESOP Grant
The NRC has granted a total of 23,211,370 (Twenty Three Million Two Hundred Eleven Thousand Three Hundred and Seventy) Employee Stock Options to eligible employees. Each option, upon exercise, entitles the holder to one fully paid-up equity share of the Company with a face value of Re. 1/- (Rupee One only). The following table summarises the key parameters of this grant:
| Parameter: | Details |
|---|---|
| Total Options Granted: | 23,211,370 |
| Exercise Price per Option: | INR 121.21 |
| Face Value per Share: | Re. 1/- |
| Vesting Period: | Minimum 1 year, Maximum 5 years from date of grant |
| Exercise Period: | Maximum 3 years from date of each vesting |
| Scheme Compliance: | SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 |
| Scheme Administrator: | Motherson ESOP Trust |
Scheme Structure and Significant Terms
The ESOP Scheme 2025 is administered by the Motherson ESOP Trust, to the extent that aspects of such administration are delegated by the Committee in accordance with applicable laws. The scheme is overseen by the Nomination and Remuneration Committee, which handles all related responsibilities, including any powers or duties delegated by the Board. Key structural features of the scheme include:
- The scheme is applicable to the Company (and any successor), its employees, as well as group companies and subsidiary companies in India or abroad, and their eligible employees or eligible directors.
- The specific employees to whom options are granted, along with their eligibility criteria, are determined by the Committee upon recommendation of the management.
- Options granted shall vest not earlier than a minimum vesting period of one (1) year and not later than a maximum vesting period of five (5) years from the date of grant.
- The exercise period for vested options shall be a maximum of 3 (Three) years commencing from the date of each vesting, or such shorter period as may be prescribed by the Committee.
- Shares arising out of the exercise of vested options shall not be subject to any lock-in from the date of transfer of such shares under the ESOP Scheme 2025.
- Employees exercising options are also liable to pay the Company an amount equivalent to the perquisite tax payable on exercise, in accordance with the Income Tax Act and other applicable laws at the relevant time.
Regulatory Compliance
The ESOP Scheme 2025 is in compliance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The disclosure was made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, read with SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026. Parameters such as options vested, options exercised, money realised by exercise, total shares arising from exercise, options lapsed, variation of terms, subsequent changes or cancellations, and diluted earnings per share are not applicable at this stage, as the current disclosure pertains solely to the grant of options under the ESOP Scheme 2025.
Historical Stock Returns for Samvardhana Motherson International
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.96% | +1.75% | +19.29% | +21.94% | +37.58% | +57.20% |
How might the dilution of approximately 23.2 million shares impact Samvardhana Motherson's earnings per share and existing shareholder value once employees begin exercising their options after the minimum one-year vesting period?
Given the exercise price of INR 121.21, how does this benchmark against Samvardhana Motherson's expected stock performance trajectory, and will it be sufficient to retain and incentivize key talent in a competitive auto components market?
Could this ESOP grant signal Samvardhana Motherson's intent to accelerate expansion into new geographies or business verticals, and which employee segments or subsidiaries are likely to be the primary beneficiaries?


































